A phase 2, proof-of-concept, placebo-controlled, randomized, multicenter, double-blind study to evaluate the efficacy, safety, tolerability, pharmacokinetics, and pharmacodynamics of Usnoflast (ZYIL1) in patients with amyotrophic lateral sclerosis
用户jSYlGZSX4UHM
4小时前
17
10
已完结
1. 当前求助状态已完结, 请及时下载应助文件
2. 系统将在 2025-10-31 15:39:38 删除文件
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1080/21678421.2025.2515900
文献链接: https://www.tandfonline.com/doi/full/10.1080/21678421.2025.2515900
其他信息:
出版社: Informa UK Limited
作者: Amit Yeole; Laxmi Khanna; Maulik Doshi; Arvind Sharma; Pratik Uttarwar; Suyog Doshi; Rana Kaushik Kumar; N. Venkataramana; Deven Parmar
